Predictive value of hematological markers of systemic inflammation for managing cervical cancer

Lin Wang; Jing Jia; Lu Lin; Junying Guo; Xingming Ye; Xiongwei Zheng; Ying Chen

doi:10.18632/oncotarget.14827

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Clinical Research Papers:

Predictive value of hematological markers of systemic inflammation for managing cervical cancer

Lin Wang _, Jing Jia, Lu Lin, Junying Guo, Xingming Ye, Xiongwei Zheng and Ying Chen

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2017; 8:44824-44832. https://doi.org/10.18632/oncotarget.14827

Metrics: PDF 1909 views | HTML 4461 views | ?

Abstract

Lin Wang1, Jing Jia1, Lu Lin1, Junying Guo1, Xingming Ye1, Xiongwei Zheng1,* and Ying Chen1,*

1 Fujian Provincial Cancer Hospital, The Affiliated Cancer Hospital of Fujian Medical University, Fuzhou, China

* These authors have contributed equally to this work

Correspondence to:

Ying Chen, email:

Xiongwei Zheng, email:

Keywords: Cervical cancer, metastasis, neutrophil/lymphocyte ratio, platelet/ lymphocyte ratio

Received: March 27, 2016 Accepted: January 16, 2017 Published: January 26, 2017

Abstract

The neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR), and red cell distribution width (RDW) are markers of systemic inflammation with prognostic significance for cancers. The aim of the study was to investigate the predictive significance of pretreatment values of NLR, PLR, and RDW in cervical cancer. We retrospectively analyzed 515 patients with cancer. Median values of NLR and PLR were higher in patients with cancer compared with controls and were consistently elevated during tumor progression, while the RDW was uninformative. Increased NLR was associated with lymph node (LN) metastasis and depth of stromal infiltration, and increased PLR correlated only with LN metastasis. The pretreatment NLR or PLR value was a significant predictor of LN metastasis, which enhanced when NLR and PLR values were combined. Further, NLR and PLR were as effective as squamous cell carcinoma antigen (SCC-Ag) for predicting distant tumor metastasis. However, no prognostic significance of NLR or PLR was found in the patients with early cancer stages. Our study suggested that pretreatment values of NLR and PLR might be helpful to predict the presence of distant and LN metastasis in patients with cervical carcinoma, but not adequate prognostic factors for early stage patients.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 14827

Publication Alerts

Clinical Research Papers:

Predictive value of hematological markers of systemic inflammation for managing cervical cancer

Abstract